Ali Fattaey, Ph.D., has been appointed president and chief operating officer at Curis, Inc. Dr. Fattaey will join the senior management team, and will be responsible for the oversight and implementation of the company’s R&D operations.   Dr. Fattaey has held leadership positions at several cancer-focused organizations and brings significant R&D experience, including eight years at Onyx Pharmaceuticals, where he was responsible for multiple programs in partnership with Pfizer and Ba...